Screener
Bausch Health Companies BHC Diversified — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| (in millions) | Three Months Ended March 31, / Salix / 2026 | Three Months Ended March 31, / Salix / 2025 | Three Months Ended March 31, / International / 2026 | Three Months Ended March 31, / International / 2025 | Three Months Ended March 31, / Solta Medical / 2026 | Three Months Ended March 31, / Solta Medical / 2025 | Three Months Ended March 31, / Diversified / 2026 | Three Months Ended March 31, / Diversified / 2025 | Three Months Ended March 31, / Bausch + Lomb / 2026 | Three Months Ended March 31, / Bausch + Lomb / 2025 | Three Months Ended March 31, / Total / 2026 | Total / 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | $639 | $542 | $285 | $262 | $171 | $113 | $185 | $205 | $1,244 | $1,137 | $2,524 | $2,259 |
| Less: | ||||||||||||
| Cost of goods sold (a) | 47 | 43 | 112 | 102 | 53 | 27 | 27 | 30 | 482 | 481 | ||
| Cost of other revenues | — | — | 16 | 17 | — | — | — | — | 1 | 1 | ||
| Selling, general and administrative | 105 | 111 | 63 | 52 | 35 | 28 | 43 | 45 | 439 | 447 | ||
| Research and development | 19 | 17 | 6 | 6 | 8 | 5 | 3 | 3 | 45 | 28 | ||
| Segment profit | $468 | $371 | $88 | $85 | $75 | $53 | $112 | $127 | $277 | $180 | $1,020 | $816 |
| Corporate | (258) | (268) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's diversified — revenue?
- Bausch Health Companies (BHC) reported diversified — revenue of $185M in Q1 2026.
- How has Bausch Health Companies's diversified — revenue changed year-over-year?
- Bausch Health Companies's diversified — revenue decreased by 9.8% year-over-year, from $205M to $185M.
- What is the long-term trend for Bausch Health Companies's diversified — revenue?
- Over 4 years (2021 to 2025), Bausch Health Companies's diversified — revenue has grown at a -4.4% compound annual growth rate (CAGR), from $1.12B to $937M.
- What does diversified — revenue mean?
- Represents the total gross revenue generated from the sale of products and services within the Diversified segment, net of returns and allowances. This is the primary measure of the segment's market demand and top-line growth performance. It provides insight into the segment's contribution to the overall corporate revenue stream.
Ask your AI about Bausch Health Companies's diversified — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude